Advertisement Nfocus Neuromedical names new board chairman - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Nfocus Neuromedical names new board chairman

Nfocus Neuromedical, a developer of next-generation endovascular neurosurgery solutions, has appointed Eric Milledge as its new chairman of the board.

Mr Milledge began with Johnson & Johnson in 1973. Mr Milledge later held positions of company group chairman of Johnson & Johnson Health Care Systems, president of Ortho-McNeil, and president of Ortho Pharmaceutical Corporation.

Martin Dieck, president and CEO of Nfocus Neuromedical, said: “Mr Milledge brings exceptional industry experience, business acumen and leadership to Nfocus, as we advance our pursuit of technologies in the field of endovascular neurosurgery.”